Laverock Therapeutics, established in 2021 to commercialise the gene editing induced gene silencing (GEiGS^®) platform for all human therapeutic applications, has expanded its seed funding round to £13.5M. This investment was led by Calculus Capital with additional participation by Eli Lilly and Company, Mercia Ventures, Maven Capital Partners, Eos, UK Innovation & Science Seed Fund and Tekfen Ventures.

Navenio, the UK location tech scaleup, has announced its £5m million investment to help revolutionise healthcare efficiency worldwide. The round was led by Oxford Science Enterprises, and saw Navenio’s existing investors, including G.K. Goh Ventures, Big Pi Ventures, George Robinson, and the University of Oxford, participate. 

Three North East based investment funds have combined forces with a biotech industry specialist to support Newcastle University’s latest spin out company, MarraBio Ltd. Maven Capital Partners, CPI Enterprises, Northstar Ventures, and TCS Biosciences have together provided MarraBio with an initial round of seed investment funding.

Kuano, a Cambridge-based drug discovery company combining quantum mechanics with AI to design the next generation of medicines, has closed a £1.8m seed funding round led by Mercia Ventures and including ACF Investors, Ascension Ventures, o2h Ventures, Meltwind Advisory LLP and other angel investors.

Integrated drug formulation and clinical trials company, BDD has secured a further round of investment for £2M to aid the company’s expansion in response to growing demand for both its patented drug delivery technology and specialist clinical trial services.

Seattle, USA: Wavely Diagnostics, Inc., a digital diagnostics company developing smartphone-based apps to bring accurate, data-driven virtual pediatric care into every U.S. household, has raised $1.35MM in new funding to advance its first-of-its-kind digital diagnostics platform for enabling virtual ear infection care for children, bringing Wavely’s total investor and grant funding to $6.35MM. The new funding will enable Wavely to seize upon growing interest from healthcare systems and pediatric care providers and accelerate development ahead of its planned public release in app stores later this year. 

Cytomos, an Edinburgh-based life science company that has developed a proprietary new approach to analysing cells, has secured £4 million to scale up market-testing of its technology platform Cytomos Dielectric Spectroscopy (CDS).

Béa Fertility, the pioneering fertility tech startup making clinical-grade fertility care available at home, has raised £2.5m/$3.2m to release its first groundbreaking at-home fertility treatment to early adopters in the UK.

ITALY: 1000Farmacie has announced the completion of the second tranche of its Series A round, raising an additional $10M for a total of $25M. 

Remedial Health, a healthtech startup that develops solutions to make Africa’s pharmaceutical value chain more efficient, has secured $12 million in an equity and debt funding round to deepen the penetration of its services in Nigeria and support the delivery of targeted financial services to drive business growth across the country’s pharmaceutical sector.

thymia, a healthtech startup building gamified AI tools to revolutionise how we assess and monitor mental health, raised $2.7 million seed funding to expand the reach and capabilities of its pioneering technology.

London-based consumer health startup Berry Health raised $1.6m from Lightspeed Venture Partners and General Catalyst to democratize access to healthcare in Africa, starting out with mental health, sexual health and dermatology.